Skip to main content

Table 1 Summary of characteristics of arenavirus-derived HLA-DRB1*0101-restricted CD4+ T cell epitopes.

From: Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage

Epitopea

Sequence

DRB1*0101 binding affinity

(IC50 nM)b

ELISPOT

(net SFC/106 CD4+)c

ICS

(%IFN-γ+ CD4+)d

GTOV GPC131-145

KGSPEFDWILGWTIK

1.7

208

0.22

GTOV L181-195

DQEYHRLIHSLSKTS

0.34

390

0.05

GTOV L391-405

RVLDILVARRLLLKK

0.19

330

0.11

GTOV L1826-1840

IQLVFSSMINPLVIT

0.23

163

0.04

GTOV NP166-180

KLNNQFGSMPALTIA

0.12

122

0.05

GTOV NP191-205

NNVVQALTSLGLLYT

0.29

97

0.05

GTOV NP236-250

ISGYNFSLSAAVKAG

0.12

126

0.03

GTOV NP541-555

IPIQLLPNTLVFQAK

0.25

142

0.11

JUNV GPC46-60

FFVFLALAGRSCTEE

0.23

684

0.06

JUNV L381-395

VGQMLMLVNDRLLDI

0.21

323

0.06

JUNV L391-405

RLLDILEAIKLIRKK

0.48

333

0.08

JUNV L411-425

KWVQMCSRTLKNSHQ

1.1

571

0.05

JUNV L1491-1505

MFIRNCARKVFNDIK

2.0

425

0.11

JUNV L1711-1725

NKNFFWAVKPKAVRQ

0.06

538

0.16

LASV GPC236-250

PSPIGYLGLLSQRTR

0.14

497

0.07

LASV GPC241-255

YLGLLSQRTRDIYIS

0.29

469

0.05

LASV GPC476-490

SCGLYKQPGVPVRWK

1.5

273

0.04

LCMV GPC421-435

LRKDYIKRQGSTPLA

4.8

268

0.16

LCMV L256-270

RNFQKVNPEGLIKEF

5.6

217

0.07

LCMV L946-960

HLRKVILSEISFHLV

2.1

533

0.07

LCMV NP6-20

EVKSFQWTQALRREL

49

436

0.07

LCMV NP521-535

MDCIIFESASKARLP

4.4

463

0.12

MACV GPC96-110

NSFYYMKGGVNTFLI

0.21

365

0.08

MACV GPC251-265

SKTHLNFERSLKAFF

1.7

427

0.12

MACV GPC446-460

ASLFLHLVGIPTHRH

0.13

329

0.08

MACV L391-405

DRVLDILEAVKLIRK

0.48

423

0.22

MACV L636-650

RYFLMAFANQIHHID

0.24

269

0.06

MACV L866-880

DYLILKNLTGLVSAG

0.21

322

0.13

MACV L1491-1505

TSFIRNCARKVFNDI

0.11

400

0.07

MACV L1711-1725

NNQNFFWAVKPKVVR

1.7

518

0.09

MACV NP191-205

NSVVQALTSLGLLYT

0.78

176

0.06

MACV Z21-35

PSAEFRRTAPPSLYG

2.0

313

0.16

SABV GPC26-40

VSLIAALKGMINLWK

0.47

264

0.04

SABV GPC436-450

FTTTLFLHLVGFPTH

0.92

1213

0.08

SABV GPC441-455

FLHLVGFPTHRHIRG

0.09

823

0.05

WWAV GPC46-60

FIVFLLLAGRSCSYK

1.2

701

0.10

WWAV GPC386-400

FRNQWLLESDHLISE

1.6

517

0.39

  1. a Peptide position within the GPC, L, NP, or Z protein of prototypic strains of GTOV, JUNV, LASV, LCMV, MACV, SABV, and WWAV.
  2. b Each epitope was tested for binding to HLA-DRB1*0101.
  3. c Peptide tested at 10 μg/ml in IFN-γ ELISPOT assays. Criteria for positivity are net SFC/106 cells ≥ 20, SI ≥ 1.4, and p-value ≤ 0.05 in two or more independent assays. Average IFN-γ responses are shown from two independent experiments.
  4. d Peptide tested at 3 μg/ml in IFN-γ ICS assays. The epitope-specific responses were calculated by subtracting the total number of cells that scored positive for IFN-γ+ production in the absence of peptide. Criterion for positivity is SI ≥ 2.0 in two or more independent assays. Average IFN-γ responses are shown from two independent experiments.